KALTF
Kalytera Therapeutics Inc

127
52W High
$0.00
Volume
25.00
52W Low
$0.00
Price
$0.00
50D MA
$0.00
KALTF Fundamentals
Beta
0.00
Avg. Volume
0.00
Loading...
Loading...

About

Claritas Pharmaceuticals, Inc. engages in the development of next generation cannabinoid therapeutics. It also offers development programs for bone fracture healing, osteogenesis imperfecta, osteoporosis, and osteoporosis in Prader-Willi syndrome. The company was founded by Seth Yakatan on October 15, 2004 and is headquartered in San Rafael, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

Latest KALTF News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.